Further evidence for a role of endothelin-1 (ET-1) in critical limb ischaemia

Journal of Cell Communication and Signaling

Volumn 5, Issue 1, 2011, Pages 45-49

  Dashwood, Michael Richard ^a   Tsui, Janice C S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; Endothelin receptors; Endothelin 1; Ischaemia

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR;

ADULT; AGED; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; HUMAN; HUMAN TISSUE; LEG AMPUTATION; LIMB ISCHEMIA; MACROPHAGE; POPLITEAL ARTERY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

EID: 79953025603     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-010-0109-8     Document Type: Conference Paper

References (19)

1. RJ Barst 2007 Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension Expert Opin Pharmacother 8 95 109 10.1517/14656566.8.1.95 1:CAS:528:DC%2BD28XhtlSrsLzM 17163810 (Pubitemid 46070832)
2. NE Cameron KC Dines MA Cotter 1994 The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats Diabetologia 37 12 1209 1215 10.1007/BF00399794 1:CAS:528:DyaK2MXjvVKnt7Y%3D 7895950 (Pubitemid 24356760)
3. 125I]-ET-1 binding sites on human peripheral nerve Endothelium 5 2 119 123 10.3109/ 10623329709079870 1:CAS:528:DyaK2sXjvF2ksbs%3D 9237046 (Pubitemid 27273681)
4. 125I]-ET-1 binding to perivascular nerves of human epicardial coronary arteries Endothelium 4 231 234 10.3109/10623329609024699 1:CAS:528:DyaK28XlsFSmsLc%3D (Pubitemid 26308287)
5. MR Dashwood M Timm JR Muddle AC Ong JR Tippins R Parker D McManus AJ Murday BP Madden JC Kaski 1998 Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease Endothelium 6 1 61 70 10.3109/10623329809053405 1:CAS:528:DyaK1cXntVKht78%3D 9832333 (Pubitemid 28490875)
6. CP Denton M Humbert L Rubin CM Black 2006 Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions Ann Rheum Dis 65 1336 1340 10.1136/ard.2005.048967 1:CAS:528:DC%2BD28Xht1egsLbF 16793845 (Pubitemid 44620443)
7. JH Korn M Mayes M Matucci Cerinic M Rainisio J Pope E Hachulla E Rich P Carpentier J Molitor JR Seibold V Hsu L Guillevin S Chatterjee HH Peter J Coppock A Herrick PA Merkel R Simms CP Denton D Furst N Nguyen M Gaitonde Black 2004 Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist Arthritis Rheum 50 3985 3993 10.1002/art.20676 1:CAS:528:DC%2BD2MXls1eguw%3D%3D 15593188 (Pubitemid 39643947)
8. A Lerman BS Edwards JW Hallett DM Heublein SM Sandberg JC Burnett Jr 1991 Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis N Engl J Med 325 14 997 1001 10.1056/NEJM199110033251404 1:STN:280: DyaK3MzmtVWhug%3D%3D 1886637
9. RA Mangiafico LS Malatino M Santonocito F Sarnataro S Dell'Arte R Messina B Santangelo 1999 Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages Panminerva Med 41 1 22 26 1:STN:280:DyaK1M3ks1yltQ%3D%3D 10230252
10. DJ Newton F Khan M McLaren G Kennedy JJ Belch 2005 Endothelin-1 levels predict 3-year survival in patients who have amputation for critical limb ischaemia Br J Surg 92 11 1377 1381 10.1002/bjs.5144 1:CAS:528: DC%2BD2MXht1Cns7%2FL 16187255 (Pubitemid 41546635)
11. G Remuzzi A Benigni 1993 Endothelins in the control of cardiovascular and renal function Lancet 342 589 593 10.1016/0140-6736(93)91414-H 1:CAS:528:DyaK3sXmtFOmsrw%3D 8102724 (Pubitemid 23259238)
12. GM Rubanyi MA Polokoff 1994 Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology Pharmacol Rev 46 3 325 415 1:CAS:528:DyaK2cXmvFarurs%3D 7831383
13. TV Schroeder 2007 The TASC II- Inter-Society Consensus for management of peripheral arterial disease Eur J Vasc Endovasc Surg 33 Suppl 1 S1 76
14. Second European Consensus Document on chronic critical limb ischaemia (1991) Circulation 82(4 Suppl):IV1-26.
15. JC Tsui MR Dashwood 2005 A role for endothelin-1 in peripheral vascular disease Curr Vasc Pharmacol 3 4 325 332 10.2174/157016105774329444 1:CAS:528:DC%2BD2MXhtVaht7jJ 16248775 (Pubitemid 41264284)
16. JC Tsui DM Baker E Biecker S Shaw MR Dashwood 2002 Potential role of endothelin 1 in ischaemia-induced angiogenesis in critical leg ischaemia Br J Surg 89 741 747 10.1046/j.1365-2168.2002.02100.x 1:STN:280: DC%2BD383ovVSqug%3D%3D 12027984 (Pubitemid 34595699)
17. M Yasuda M Kohno A Tahara H Itagane I Toda K Akioka M Teragaki H Oku K Takeuchi T Takeda 1990 Circulating immunoreactive endothelin in ischemic heart disease Am Heart J 119 4 801 806 10.1016/S0002-8703(05)80315-1 1:STN:280:DyaK3c3gvFygsw%3D%3D 2138844 (Pubitemid 20133877)
18. AM Zeiher H Goebel V Schächinger C Ihling 1995 Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina Circulation 91 4 941 947 1:STN:280:DyaK2M7ltlyltg%3D%3D 7850978
19. I Ziv G Fleminger R Djaldetti A Achiron E Melamed M Sokolovsky 1992 Increased plasma endothelin-1 in acute ischemic stroke Stroke 23 7 1014 1016 1:STN:280:DyaK38zhtF2luw%3D%3D 1615534